Dichloromethane → Methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-tert-butoxyacetate
反応式
[Br:1][C:2]1[CH:18]=[C:5]2[N:6]=[C:7]([CH3:17])[C:8]([CH:11]([OH:16])[C:12]([O:14][CH3:15])=[O:13])=[C:9]([Cl:10])[N:4]2[N:3]=1.C(Cl)Cl.Cl(O)(=O)(=O)=O>C(OC(C)(C)C)(=O)C>[Br:1][C:2]1[CH:18]=[C:5]2[N:6]=[C:7]([CH3:17])[C:8]([CH:11]([O:16][C:8]([CH3:11])([CH3:9])[CH3:7])[C:12]([O:14][CH3:15])=[O:13])=[C:9]([Cl:10])[N:4]2[N:3]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a suspension of methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-hydroxyacetate (80 mg, 0.239 mmol) in tert-butyl acetate (2 mL) at room temperature was added CH2Cl2 (2 mL) followed by perchloric acid (0.022 mL, 0.359 mmol). The reaction mixture was stirred for 4 h at room temperature. The reaction mixture was quenched with water and diluted with ethyl acetate. The organic phase was washed with saturated NaHCO3 and dried over sodium sulfate. The solvent was evaporated. Purification by silica gel chromatography provided the title compound (56 mg, 59.9%). 1H NMR (500 MHz, MeOD) δ ppm 1.27 (9H, s), 2.62 (3H, s), 3.74 (3H, s), 5.75 (1H, s), 6.75 (1H, s).
後処理
- customThe reaction mixture was quenched with water
- additiondiluted with ethyl acetate
- washThe organic phase was washed with saturated NaHCO3
- dry with materialdried over sodium sulfate
- customThe solvent was evaporated
- customPurification by silica gel chromatography
出典と根拠
- ORDレコード
- ord-78f4b62eb71d4f23aac0f203f966e7ba
- 出典データセット
- uspto-grants-2014_01
- 特許番号
- US08633200B2
反応ノート
読み込み中…